Nr | Peptide | HLA | Sample/cell line source | BMI |
1 | WTEGQSNHSTGY | A*01:01 | OVCA-G1, ALL-1833, AML-4443, AML-10197 | 43 |
2 | VLDFAPPGASAY | A*01:01 | AML-4443 | 36 |
3 | ALLPAVPSL | A*02:01 | OVCA-L23 | 31 |
4 | VLDFAPPGA | A*02:01 | OVCA-L23 | 26 |
5 | FGPPPPSQA | A*02:01 | OVCA-L23, AML-10197 | 42 |
6 | AQFPNHSFK | A*03:01 | Cell line-COV362.4 | 20 |
7 | HAAQFPNHSF | B*35:01 | HCL-4512 | 36 |
8 | TPYSSDNLY | B*35:01 | ALL-2184 | 41 |
9 | RMFPNAPYL | A*02:01 | x | x |
10 | CMTWNQMNL | A*02:01 | x | x |
11 | RWPSCQKKF | A*24:02 | x | x |
12 | CMTWNQMNL | A*24:02 | x | x |
Overview of the 12 WT1 peptides included in this study. For the eight WT1 peptides identified in our HLA ligandome analyses, the source and best Mascot ion score (BMI) is listed. The four peptides not identified in this study, but previously described in literature, were added at the end of the table.
ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; BMI, Best Mascot Ion; HCL, hairy cell leukemia; OVCA, primary ovarian carcinoma.